214
Views
28
CrossRef citations to date
0
Altmetric
Liver and Biliary Disease

Impact of the MELD allocation after its implementation in liver transplantation

, , , , , , & show all
Pages 941-948 | Received 17 Jan 2011, Accepted 26 Feb 2011, Published online: 28 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Aastha Sethi, Michelle M Estrella, Richard Ugarte & Mohamed G Atta. (2011) Kidney function and mortality post-liver transplant in the Model for End-Stage Liver Disease era. International Journal of Nephrology and Renovascular Disease 4, pages 139-144.
Read now

Articles from other publishers (27)

François M. Carrier, Christian Vincelette, Helen Trottier, Éva Amzallag, Adrienne Carr, Prosanto Chaudhury, Khaled Dajani, René Fugère, Jeanne-Marie Giard, Nelson Gonzalez-Valencia, Alexandre Joosten, Stanislas Kandelman, Constantine Karvellas, Stuart A. McCluskey, Timur Özelsel, Jeieung Park, Ève Simoneau & Michaël Chassé. (2023) Perioperative clinical practice in liver transplantation: a cross-sectional surveyPratique clinique périopératoire en transplantation hépatique : un sondage transversal. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 70:7, pages 1155-1166.
Crossref
Amine Benmassaoud, Davide Roccarina, Francesco Marcello Arico, Cilla Marta, Rossella Donghia, Gioacchino Leandro, Laura Iogna Prat, Mohamed Zuhair, Matthew North, Orla Kearney, John Ryan & Emmanuel A. Tsochatzis. (2022) Sex is a major effect modifier between body composition and mortality in patients with cirrhosis assessed for liver transplantation. Liver International 43:1, pages 160-169.
Crossref
Min Yang, Bo Peng, Quan Zhuang, Junhui Li, Hong Liu, Ke Cheng & Yingzi Ming. (2022) Models to predict the short-term survival of acute-on-chronic liver failure patients following liver transplantation. BMC Gastroenterology 22:1.
Crossref
Marcos Mucenic, Ajacio Bandeira de Mello Brandão & Claudio Augusto Marroni. (2022) Artificial intelligence and human liver allocation: Potential benefits and ethical implications. Artificial Intelligence in Gastroenterology 3:1, pages 21-27.
Crossref
Paul V. Ritschl, Leke Wiering, Tomasz Dziodzio, Maximilian Jara, Jochen Kruppa, Uwe Schoeneberg, Nathanael Raschzok, Frederike Butz, Brigitta Globke, Philippa Seika, Max Maurer, Matthias Biebl, Wenzel Schöning, Moritz Schmelzle, Igor M. Sauer, Frank Tacke, Robert Öllinger & Johann Pratschke. (2020) The Effects of MELD-Based Liver Allocation on Patient Survival and Waiting List Mortality in a Country with a Low Donation Rate. Journal of Clinical Medicine 9:6, pages 1929.
Crossref
Simone Khouzam, Duilio Pagano, Marco Barbàra, Davide Cintorino, Sergio Li Petri, Fabrizio di Francesco, Calogero Ricotta, Pasquale Bonsignore, Aurelio Seidita, Sergio Calamia, Marco Canzonieri, Alessandro Tropea & Salvatore Gruttadauria. (2019) Impact of Italian Score for Organ Allocation System on Deceased Donor Liver Transplantation: A Monocentric Competing Risk Time-to-Event Analysis. Transplantation Proceedings 51:9, pages 2860-2864.
Crossref
Jonathan E. H. LingMichael FinkGlen WestallPeter MacdonaldPhilip A. ClaytonRhonda HoldsworthHelen OpdamKevan R. PolkinghorneJohn Kanellis. (2019) Risk Indices in Deceased-donor Organ Allocation for Transplantation: Review From an Australian Perspective. Transplantation 103:5, pages 875-889.
Crossref
Deepika Devuni & Jawad Ahmad. 2017. Biomarkers in Liver Disease. Biomarkers in Liver Disease 47 70 .
Georgios C. Sotiropoulos, Spyridon Vernadakis, Andreas Paul, Dieter P. Hoyer, Fuat H. Saner & Anja Gallinat. (2016) Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients. Digestive Diseases and Sciences 61:11, pages 3346-3353.
Crossref
Juan Jurado-García, María Muñoz García-Borruel, Manuel Luis Rodríguez-Perálvarez, Patricia Ruíz-Cuesta, Antonio Poyato-González, Pilar Barrera-Baena, Enrique Fraga-Rivas, Guadalupe Costán-Rodero, Javier Briceño-Delgado, José Luis Montero-Álvarez & Manuel de la Mata-García. (2016) Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality. PLOS ONE 11:6, pages e0155822.
Crossref
S. Trapani, V. Morabito, A. Oliveti, D. Peritore, A. Rizzo, A.R. Cacciotti, A. Gaeta, A. Montemurro, L. Rizzato & A. Nanni Costa. (2016) Liver Allocation in Urgent MELD Score ≥30: The Italian Experience. Transplantation Proceedings 48:2, pages 299-303.
Crossref
Maria Isis Freire de Aguiar, Violante Augusta Batista Braga, Paulo César de Almeida, José Huygens Parente Garcia & Clébia Azevedo de Lima. (2016) Gravidade da doença hepática e qualidade de vida no transplante de fígado. Acta Paulista de Enfermagem 29:1, pages 107-114.
Crossref
Matthias Pinter, Michael Trauner, Markus Peck-Radosavljevic & Wolfgang Sieghart. (2016) Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open 1:2, pages e000042.
Crossref
Deepika Devuni & Jawad Ahmad. 2016. Biomarkers in Liver Disease. Biomarkers in Liver Disease 1 24 .
Naveen Ganjoo & Thomas D. Schiano. 2016. Disease Recurrence After Liver Transplantation. Disease Recurrence After Liver Transplantation 165 186 .
Sumeet K. Asrani & Patrick S. Kamath. (2015) Model for end-stage liver disease score and MELD exceptions: 15 years later. Hepatology International 9:3, pages 346-354.
Crossref
Dieter P. Hoyer, Andreas Paul, Fuat Saner, Anja Gallinat, Zoltan Mathé, Juergen W. Treckmann, Maren Schulze, Gernot M. Kaiser, Ali Canbay, Ernesto Molmenti & Georgios C. Sotiropoulos. (2015) Safely expanding the donor pool: brain dead donors with history of temporary cardiac arrest. Liver International 35:6, pages 1756-1763.
Crossref
Khalid Khwaja & Elizabeth A. Pomfret. 2015. Transplantation of the Liver. Transplantation of the Liver 64 71 .
Dieter P. Hoyer, Georgios C. Sotiropoulos, Fuat H. Saner, Jürgen W. Treckmann, Andreas Paul & Zoltan Mathé. (2014) MELD at POD 1 as a predictor of outcome in liver allografts with peak AST >5000 U/l. Transplant International 27:12, pages 1285-1293.
Crossref
Helge Bruns, Vladimir J. Lozanovski, Daniel Schultze, Norbert Hillebrand, Ulf Hinz, Markus W. Büchler & Peter Schemmer. (2014) Prediction of Postoperative Mortality in Liver Transplantation in the Era of MELD-Based Liver Allocation: A Multivariate Analysis. PLoS ONE 9:6, pages e98782.
Crossref
Emily Dannhorn & James P O’Beirne. (2013) Liver transplantation for HIV/HCV coinfection: where is the controversy?. Future Virology 8:7, pages 639-648.
Crossref
Christoph Lichtenstern, Marcel Hochreiter, Verena D. Zehnter, Thorsten Brenner, Stefan Hofer, Markus Mieth, Markus W. Büchler, Eike Martin, Markus A. Weigand, Peter Schemmer & Cornelius J. Busch. (2013) Pretransplant model for end stage liver disease score predicts posttransplant incidence of fungal infections after liver transplantation. Mycoses 56:3, pages 350-357.
Crossref
Adriana Gonçalves da Silva Machado, Alfeu de Medeiros Fleck Jr.Cláudio Marroni, Maria Lúcia Zanotelli, Guido Cantisani & Ajácio Bandeira de Mello Brandão. (2013) Impact of MELD score implementation on liver allocation: experience at a Brazilian center. Annals of Hepatology 12:3, pages 440-447.
Crossref
Armin Finkenstedt, Livia Dorn, Michael Edlinger, Wolfgang Prokop, Lorenz Risch, Andrea Griesmacher, Ivo Graziadei, Wolfgang Vogel & Heinz Zoller. (2012) Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?. Liver International 32:8, pages 1211-1216.
Crossref
Markus Quante, Christoph Benckert, Armin Thelen & Sven Jonas. (2012) Experience Since MELD Implementation: How Does the New System Deliver?. International Journal of Hepatology 2012, pages 1-5.
Crossref
In Cho, Dong Jin Joo, Myoung Soo Kim, Dong Eun Yong, Kyu Ha Huh, Gi Hong Choi, Jin Sub Choi & Soon Il Kim. (2011) Impact of Early Positive Culture Results on the Short-term Outcomes of Liver Transplants. Korean Journal of Transplantation 25:4, pages 257-263.
Crossref
Sumeet K. Asrani & W. Ray Kim. (2011) Model for End-Stage Liver Disease: End of the First Decade. Clinics in Liver Disease 15:4, pages 685-698.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.